Literature DB >> 18802095

CD8 T cells utilize TRAIL to control influenza virus infection.

Erik L Brincks1, Arna Katewa, Tamara A Kucaba, Thomas S Griffith, Kevin L Legge.   

Abstract

Elimination of influenza virus-infected cells during primary influenza virus infections is thought to be mediated by CD8(+) T cells though perforin- and FasL-mediated mechanisms. However, recent studies suggest that CD8(+) T cells can also utilize TRAIL to kill virally infected cells. Therefore, we herein examined the importance of TRAIL to influenza-specific CD8(+) T cell immunity and to the control of influenza virus infections. Our results show that TRAIL deficiency increases influenza-associated morbidity and influenza virus titers, and that these changes in disease severity are coupled to decreased influenza-specific CD8(+) T cell cytotoxicity in TRAIL(-/-) mice, a decrease that occurs despite equivalent numbers of pulmonary influenza-specific CD8(+) T cells. Furthermore, TRAIL expression occurs selectively on influenza-specific CD8(+) T cells, and high TRAIL receptor (DR5) expression occurs selectively on influenza virus-infected pulmonary epithelial cells. Finally, we show that adoptive transfer of TRAIL(+/+) but not TRAIL(-/-) CD8(+) effector T cells alters the mortality associated with lethal dose influenza virus infections. Collectively, our results suggest that TRAIL is an important component of immunity to influenza infections and that TRAIL deficiency decreases CD8(+) T cell-mediated cytotoxicity, leading to more severe influenza infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802095      PMCID: PMC2610351          DOI: 10.4049/jimmunol.181.7.4918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  The CD8 response on autopilot.

Authors:  M J Bevan; P J Fink
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection.

Authors:  Kevin L Legge; Thomas J Braciale
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

3.  Dynamic programming of CD8+ T lymphocyte responses.

Authors:  Marianne J B van Stipdonk; Gijs Hardenberg; Martijn S Bijker; Edward E Lemmens; Nathalie M Droin; Douglas R Green; Stephen P Schoenberger
Journal:  Nat Immunol       Date:  2003-03-17       Impact factor: 25.606

4.  Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta.

Authors:  K Sato; S Hida; H Takayanagi; T Yokochi; N Kayagaki; K Takeda; H Yagita; K Okumura; N Tanaka; T Taniguchi; K Ogasawara
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

5.  Early programming of T cell populations responding to bacterial infection.

Authors:  R Mercado; S Vijh; S E Allen; K Kerksiek; I M Pilip; E G Pamer
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

6.  TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections.

Authors:  Jörn Sträter; Henning Walczak; Tanja Pukrop; Lutz Von Müller; Cornelia Hasel; Marko Kornmann; Thomas Mertens; Peter Möller
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

7.  Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

Authors:  J J Lum; A A Pilon; J Sanchez-Dardon; B N Phenix; J E Kim; J Mihowich; K Jamison; N Hawley-Foss; D H Lynch; A D Badley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice.

Authors:  Lisa M Sedger; Moira B Glaccum; JoAnn C L Schuh; Suzanne T Kanaly; Eilidh Williamson; Nobuhiko Kayagaki; Theordore Yun; Pam Smolak; Tiep Le; Ray Goodwin; Brian Gliniak
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

9.  Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.

Authors:  Troy J Kemp; Bennett D Elzey; Thomas S Griffith
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

View more
  104 in total

1.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 2.  Postinfluenza bacterial pneumonia: host defenses gone awry.

Authors:  Megan N Ballinger; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

3.  Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors:  Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 4.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

5.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

Authors:  Alexandre de Titta; Marie Ballester; Ziad Julier; Chiara Nembrini; Laura Jeanbart; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

6.  Co-infection: when whole can be greater than the sum: The complex reaction to co-infection of different pathogens can generate variable symptoms.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2018-07-06       Impact factor: 8.807

7.  17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.

Authors:  Dionne P Robinson; Olivia J Hall; Tricia L Nilles; Jay H Bream; Sabra L Klein
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.

Authors:  M R Starkey; D H Nguyen; A T Essilfie; R Y Kim; L M Hatchwell; A M Collison; H Yagita; P S Foster; J C Horvat; J Mattes; P M Hansbro
Journal:  Mucosal Immunol       Date:  2013-09-18       Impact factor: 7.313

9.  Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.

Authors:  Rena Brauer; Lingyin Ge; Saundra Y Schlesinger; Timothy P Birkland; Ying Huang; Tanyalak Parimon; Vivian Lee; Bonnie L McKinney; John K McGuire; William C Parks; Peter Chen
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

10.  Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.

Authors:  Hamid R Haghighi; Leah R Read; S M Mansour Haeryfar; Shahriar Behboudi; Shayan Sharif
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.